I’m very excited to join the Ziegler team. The breadth of Ziegler’s healthcare franchise and the long-term, client relationship driven culture ideally aligns with my historic investment banking practice as well as my future growth objectives.
Chicago, IL (PRWEB) January 08, 2016
Ziegler, an investment bank and full service brokerage firm, announced today the addition of Grant Chamberlain as managing director to its investment banking team in healthcare corporate finance. Mr. Chamberlain will reside in the corporate headquarters in Chicago.
Mr. Chamberlain stated, “I’m very excited to join the Ziegler team. The breadth of Ziegler’s healthcare franchise and the long-term, client relationship driven culture ideally aligns with my historic investment banking practice as well as my future growth objectives.”
With over 20 years of investment banking experience, Mr. Chamberlain has advised several of the most innovative mHealth companies, including AirStrip, MDLive and Voalte along with some of the leading healthcare systems, including Baylor Health, Cedars-Sinai and Sharp Healthcare. Prior to Ziegler, Grant led the mHealth sector coverage at Raymond James – which included telehealth, remote monitoring and wireless healthcare solutions – after spending 15 years advising HCIT and tech-enabled outsource services companies on a broad variety of M&A, joint venture/partnerships and private financings.
Additionally, Mr. Chamberlain was a principal at Shattuck Hammond Partners prior to it being acquired by Morgan Keegan. He was also a part of the corporate finance group of General Electric Capital Corporation and the financial services division of GE Medical Systems. He earned a B.A. in finance and investment banking from University of Wisconsin-Madison.
Dan Hermann, Senior Managing Director and Head of Investment Banking at Ziegler, stated, “Bringing Mr. Chamberlain to Ziegler is a significant leap forward – not only for our Midwest presence, but also for our national corporate finance healthcare practice. He has a long track record of successfully capturing, structuring and executing complex transactions while establishing himself as a deeply trusted advisor among clients.”
Neil Borg, Managing Director and Head of Corporate Finance Healthcare, stated, “I am thrilled to have Grant join the corporate finance healthcare team. His addition reinforces our ongoing commitment to be one of the leading advisors to the healthcare services and information technology sectors.”
Ziegler’s Corporate Finance team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.
For more information about Ziegler, please visit us at http://www.ziegler.com.
The Ziegler Companies, Inc., together with its affiliates (Ziegler), is a privately held, specialty investment bank with unique expertise in complex credit structures and advisory services. Nationally, Ziegler is ranked as one of the leading investment banking firms in its specialty sectors of healthcare, senior living, religion, and education, as well as general municipal and structured finance. Headquartered in Chicago, IL with regional and branch offices throughout the U.S., Ziegler provides its clients with capital raising, corporate finance, FHA/HUD, strategic advisory services and research. Ziegler serves institutional and individual investors through its wealth management and capital markets distribution channels.
Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client’s experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.
# # #